Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- South San Francisco, California
- Most recent report
- 8-K, filed Sep 1, 2026
- Incorporated
- Delaware
- Filings on record
- 242 filings
- On EDGAR
- CIK 1847367
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8 of 10
News 8 of 33
Prospectuses and Registrations 8 of 18
- S-3ASR Automatic shelf registration Mar 19, 2026
- S-8 Registration statement for an employee plan Jan 30, 2026
- 424B5 Prospectus supplement for an offering Jan 8, 2026
- 424B5 Prospectus supplement for an offering Jan 6, 2026
- S-3 Shelf registration statement Jul 3, 2025
- S-8 Registration statement for an employee plan Jun 10, 2025
- 424B3 Prospectus supplement for an offering Apr 23, 2025
- S-4 Registration statement for a merger or exchange Apr 21, 2025
Proxies 4
Ownership 8 of 129
- 4 Insider reported a trade Sep 9, 2026
- SCHEDULE 13D Large holder reported an active stake Aug 17, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 6, 2026
- 4 Insider reported a trade Aug 5, 2026
- 4 Insider reported a trade Aug 5, 2026
- 4 Insider reported a trade Aug 5, 2026
- 4 Insider reported a trade Aug 5, 2026
- 4 Insider reported a trade Aug 5, 2026
Other 8 of 48
- ARS Annual report sent to shareholders May 18, 2026
- EFFECT Notice that a registration became effective Aug 19, 2025
- CORRESP Reply to SEC staff Aug 15, 2025
- UPLOAD Comment letter from SEC staff Jul 9, 2025
- ARS Annual report sent to shareholders Jun 16, 2025
- 425 Apr 29, 2025
- EFFECT Notice that a registration became effective Apr 23, 2025
- CORRESP Reply to SEC staff Apr 22, 2025
Everything here comes from Alumis Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.